Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

07 Jan 2022 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Vortioxetine Tablets 5 mg, 10 mg, 15 mg, and 20 mg. In this regard, the company attached a press release on January 07,2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..